Jan 16, 2020

LIfT BioSciences secures a further round of funding for its game-changing innate cell therapy for solid tumours

Posted by in categories: biotech/medical, innovation

London, 15th January 2020 – Biotech LIfT BioSciences today announced a further major investment into the company in its mission to develop the first curative and affordable cell therapy for all solid tumours. The investors included Jonathan Milner, a leading biotech ‘super-angel’ investor and earlier stage investor in LIfT, Kizoo Technology Ventures, a leading early-stage investor in breakthrough technologies and Downing Ventures, a leading London-based investor.

Comments are closed.